Literature DB >> 28766039

Fungal and Bacterial Diversity of Airway Microbiota in Adults with Cystic Fibrosis: Concordance Between Conventional Methods and Ultra-Deep Sequencing, and Their Practical use in the Clinical Laboratory.

Françoise Botterel1,2, Cécile Angebault3,4, Odile Cabaret5, Franziska A Stressmann6, Jean-Marc Costa4,7, Frédéric Wallet8, Benoit Wallaert9, Kenneth Bruce10, Laurence Delhaes9,11.   

Abstract

Given the complexity of the airway microbiota in the respiratory tract of cystic fibrosis (CF) patients, it seems crucial to compile the most exhaustive and exact list of the microbial communities inhabiting CF airways. The aim of the present study was to compare the bacterial and fungal diversity of sputa from adult CF patients during non-exacerbation period by culture-based and molecular methods, and ultra-deep-sequencing (UDS). Sputum samples from four CF patients were cultured and analysed by DNA extractions followed by terminal restriction fragment length polymorphism analysis through resolution of bacterial ribosomal gene (rDNA) fragments, and cloning plus sequencing of part of fungal rRNA genes. These approaches were compared with UDS method targeting 16S rDNA gene and the internal transcribed spacer (ITS) 2 region of rDNA. A total of 27 bacterial and 18 fungal genera were detected from the four patients. Five (18%) and 3 (16%) genera were detected by culture for bacteria and fungi, respectively, 9 (33%) and 3 (16%) by first generation sequencing (FGS) methods, and 26 (96%) and 18 (100%) by UDS. The mean number of genera detected by UDS per patient was statistically higher than by culture or FGS methods. Patients with severe airway disease as assessed by standard spirometry exhibited a reduced fungal and bacterial diversity. UDS approach evaluates more extensively the diversity of fungal and bacterial flora compared with cultures. However, it currently remains difficult to routinely use UDS mainly because of the lack of standardization, and the current cost of this method.

Entities:  

Keywords:  16S rDNA; Cystic fibrosis; ITS2; Microbiome; Mycobiome; UDS

Mesh:

Substances:

Year:  2017        PMID: 28766039     DOI: 10.1007/s11046-017-0185-x

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  37 in total

Review 1.  Next-generation sequencing in the analysis of human microbiota: essential considerations for clinical application.

Authors:  Geraint B Rogers; Kenneth D Bruce
Journal:  Mol Diagn Ther       Date:  2010-12-01       Impact factor: 4.074

2.  Microbial diversity in the sputum of a cystic fibrosis patient studied with 16S rDNA pyrosequencing.

Authors:  F Armougom; F Bittar; N Stremler; J-M Rolain; C Robert; J-C Dubus; J Sarles; D Raoult; B La Scola
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-05-16       Impact factor: 3.267

Review 3.  Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis.

Authors:  Valerie Waters; Felix Ratjen
Journal:  Cochrane Database Syst Rev       Date:  2016-12-19

Review 4.  The changing microbial epidemiology in cystic fibrosis.

Authors:  John J Lipuma
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

5.  Quantitative analysis of the human airway microbial ecology reveals a pervasive signature for cystic fibrosis.

Authors:  Paul C Blainey; Carlos E Milla; David N Cornfield; Stephen R Quake
Journal:  Sci Transl Med       Date:  2012-09-26       Impact factor: 17.956

6.  Impact of antibiotic treatment for pulmonary exacerbations on bacterial diversity in cystic fibrosis.

Authors:  T W V Daniels; G B Rogers; F A Stressmann; C J van der Gast; K D Bruce; G R Jones; G J Connett; J P Legg; M P Carroll
Journal:  J Cyst Fibros       Date:  2012-06-18       Impact factor: 5.482

7.  Lack of standardization in the procedures for mycological examination of sputum samples from CF patients: a possible cause for variations in the prevalence of filamentous fungi.

Authors:  Andrew M Borman; Michael D Palmer; Laurence Delhaes; Jacqueline Carrère; Loïc Favennec; Stéphane Ranque; Jean-Pierre Gangneux; Regine Horré; Jean-Philippe Bouchara
Journal:  Med Mycol       Date:  2010-11       Impact factor: 4.076

8.  Detection of anaerobic bacteria in high numbers in sputum from patients with cystic fibrosis.

Authors:  Michael M Tunney; Tyler R Field; Thomas F Moriarty; Sheila Patrick; Gerd Doering; Marianne S Muhlebach; Matthew C Wolfgang; Richard Boucher; Deirdre F Gilpin; Andrew McDowell; J Stuart Elborn
Journal:  Am J Respir Crit Care Med       Date:  2008-02-08       Impact factor: 21.405

9.  Partitioning core and satellite taxa from within cystic fibrosis lung bacterial communities.

Authors:  Christopher J van der Gast; Alan W Walker; Franziska A Stressmann; Geraint B Rogers; Paul Scott; Thomas W Daniels; Mary P Carroll; Julian Parkhill; Kenneth D Bruce
Journal:  ISME J       Date:  2010-12-09       Impact factor: 10.302

10.  Lung microbiota across age and disease stage in cystic fibrosis.

Authors:  Bryan Coburn; Pauline W Wang; Julio Diaz Caballero; Shawn T Clark; Vijaya Brahma; Sylva Donaldson; Yu Zhang; Anu Surendra; Yunchen Gong; D Elizabeth Tullis; Yvonne C W Yau; Valerie J Waters; David M Hwang; David S Guttman
Journal:  Sci Rep       Date:  2015-05-14       Impact factor: 4.379

View more
  11 in total

1.  Fungal Respiratory Infections in Cystic Fibrosis (CF): Recent Progress and Future Research Agenda.

Authors:  Jean-Philippe Bouchara; Françoise Symoens; Carsten Schwarz; Vishnu Chaturvedi
Journal:  Mycopathologia       Date:  2018-02       Impact factor: 2.574

2.  Meta-analysis Reveals Potential Influence of Oxidative Stress on the Airway Microbiomes of Cystic Fibrosis Patients.

Authors:  Xing Shi; Zhancheng Gao; Qiang Lin; Liping Zhao; Qin Ma; Yu Kang; Jun Yu
Journal:  Genomics Proteomics Bioinformatics       Date:  2020-03-12       Impact factor: 7.691

Review 3.  Fungal-Bacterial Interactions in Health and Disease.

Authors:  Wibke Krüger; Sarah Vielreicher; Mario Kapitan; Ilse D Jacobsen; Maria Joanna Niemiec
Journal:  Pathogens       Date:  2019-05-21

4.  Respiratory mycobiome and suggestion of inter-kingdom network during acute pulmonary exacerbation in cystic fibrosis.

Authors:  Perrine Soret; Louise-Eva Vandenborght; Florence Francis; Noémie Coron; Raphael Enaud; Marta Avalos; Thierry Schaeverbeke; Patrick Berger; Michael Fayon; Rodolphe Thiebaut; Laurence Delhaes
Journal:  Sci Rep       Date:  2020-02-27       Impact factor: 4.379

5.  Lactobacillus rhamnosus probiotic prevents airway function deterioration and promotes gut microbiome resilience in a murine asthma model.

Authors:  Irina Spacova; Wannes Van Beeck; Sven Seys; Fien Devos; Jeroen Vanoirbeek; Jozef Vanderleyden; Jan Ceuppens; Mariya Petrova; Sarah Lebeer
Journal:  Gut Microbes       Date:  2020-06-10

Review 6.  Fungal Infection and Inflammation in Cystic Fibrosis.

Authors:  T Spencer Poore; Gina Hong; Edith T Zemanick
Journal:  Pathogens       Date:  2021-05-18

7.  Optimizing 16S rRNA gene profile analysis from low biomass nasopharyngeal and induced sputum specimens.

Authors:  Shantelle Claassen-Weitz; Sugnet Gardner-Lubbe; Kilaza S Mwaikono; Elloise du Toit; Heather J Zar; Mark P Nicol
Journal:  BMC Microbiol       Date:  2020-05-12       Impact factor: 3.605

Review 8.  The Mycobiome in Health and Disease: Emerging Concepts, Methodologies and Challenges.

Authors:  Pei Yee Tiew; Micheál Mac Aogain; Nur A'tikah Binte Mohamed Ali; Kai Xian Thng; Karlyn Goh; Kenny J X Lau; Sanjay H Chotirmall
Journal:  Mycopathologia       Date:  2020-01-01       Impact factor: 2.574

Review 9.  Decades-old studies of fungi associated with mammalian lungs and modern DNA sequencing approaches help define the nature of the lung mycobiome.

Authors:  Paris S Hamm; John W Taylor; Joseph A Cook; Donald O Natvig
Journal:  PLoS Pathog       Date:  2020-07-30       Impact factor: 6.823

10.  Modulated Response of Aspergillus fumigatus and Stenotrophomonas maltophilia to Antimicrobial Agents in Polymicrobial Biofilm.

Authors:  Lolita Roisin; Elise Melloul; Paul-Louis Woerther; Guilhem Royer; Jean-Winoc Decousser; Jacques Guillot; Eric Dannaoui; Françoise Botterel
Journal:  Front Cell Infect Microbiol       Date:  2020-10-06       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.